By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company enVVeno Medical Corporation

enVVeno Medical Corporation (NVNO)

NASDAQ Currency in USD
$0.79
+$0.07
+9.18%
Last Update: 11 Sept 2025, 20:00
$15.13M
Market Cap
78.60
P/E Ratio (TTM)
Forward Dividend Yield
$0.67 - $5.70
52 Week Range

NVNO Stock Price Chart

Explore enVVeno Medical Corporation interactive price chart. Choose custom timeframes to analyze NVNO price movements and trends.

NVNO Company Profile

Discover essential business fundamentals and corporate details for enVVeno Medical Corporation (NVNO) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

31 May 2018

Employees

37.00

CEO

Robert A. Berman

Description

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

NVNO Financial Timeline

Browse a chronological timeline of enVVeno Medical Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Apr 2026

Upcoming earnings on 26 Feb 2026

Upcoming earnings on 29 Oct 2025

Earnings released on 31 Jul 2025

EPS came in at -$0.33 falling short of the estimated -$0.30 by -10.00%.

Earnings released on 30 Apr 2025

EPS came in at -$0.22 surpassing the estimated -$0.34 by +35.29%.

Earnings released on 27 Feb 2025

EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%, while revenue for the quarter reached $812.00K .

Earnings released on 30 Oct 2024

EPS came in at -$0.35 falling short of the estimated -$0.33 by -6.06%.

Earnings released on 31 Jul 2024

EPS came in at -$0.31 surpassing the estimated -$0.36 by +13.89%.

Earnings released on 8 May 2024

EPS came in at -$0.31 surpassing the estimated -$0.40 by +22.50%.

Earnings released on 29 Feb 2024

EPS came in at -$0.32 surpassing the estimated -$0.46 by +30.43%, while revenue for the quarter reached $824.00K .

Earnings released on 26 Oct 2023

EPS came in at -$0.45 surpassing the estimated -$0.48 by +6.25%.

Earnings released on 31 Jul 2023

EPS came in at -$0.58 falling short of the estimated -$0.49 by -18.37%.

Earnings released on 1 May 2023

EPS came in at -$0.57 falling short of the estimated $0.48 by -218.75%.

Earnings released on 2 Mar 2023

EPS came in at -$0.55 surpassing the estimated -$0.57 by +3.51%.

Earnings released on 27 Oct 2022

EPS came in at -$0.54 falling short of the estimated -$0.52 by -3.85%.

Earnings released on 3 Aug 2022

EPS came in at -$0.63 falling short of the estimated -$0.33 by -90.91%.

Earnings released on 29 Apr 2022

EPS came in at -$0.47 falling short of the estimated -$0.29 by -62.07%.

Earnings released on 28 Mar 2022

EPS came in at -$0.94 falling short of the estimated -$0.33 by -184.85%.

Earnings released on 12 Nov 2021

EPS came in at -$0.26 surpassing the estimated -$0.34 by +23.53%.

Earnings released on 11 Aug 2021

EPS came in at -$0.28 surpassing the estimated -$0.34 by +17.65%.

Earnings released on 12 May 2021

EPS came in at -$0.48 falling short of the estimated -$0.34 by -41.18%.

Earnings released on 31 Mar 2021

EPS came in at -$2.46 falling short of the estimated -$0.98 by -151.02%, while revenue for the quarter reached $31.24K .

Stock split effective on 30 Nov 2020

Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 17 Nov 2020

EPS came in at -$1.25 matching the estimated -$1.25.

NVNO Stock Performance

Access detailed NVNO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run